One of the advantages Holst's group had in working on the issue was that researchers in Copenhagen were skilled at keeping pancreases alive that had been removed from pigs by perfusion with artificial blood
Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M
If weight is actively worsening health or if complications arise that medication could address quickly, these delays create unnecessary risk
Large cardiovascular outcome trials, including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide), have demonstrated cardiovascular risk reduction with GLP-1 receptor agonists
The impact will also be felt more broadly within the healthcare sector
These products are shown as catalogue pairings only